Exhibit 99.1
Joint Filing Agreement
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the common shares of HOOKIPA Pharma Inc. and further agree that this agreement be included as an exhibit to such filing. Each party to this agreement expressly authorizes each other party to file on its behalf any and all amendments to such statement. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts.
In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf on February 14, 2025.
| SOFINNOVA CAPITAL VI FCPR | SOFINNOVA PARTNERS SAS | |||
| By: Sofinnova Partners SAS | ||||
| By: | /s/ Antoine Papiernik | By: | /s/ Antoine Papiernik | |
| Name: | Antoine Papiernik | Name: | Antoine Papiernik | |
| Title: | Managing Partner | Title: | Managing Partner | |
| By: | /s/ Antoine Papiernik | By: | /s/ Henrijette Richter | |
| Name: | Antoine Papiernik | Name: | Henrijette Richter | |
| By: | /s/ Maina Bhaman | By: | /s/ Graziano Seghezzi | |
| Name: | Maina Bhaman | Name: | Graziano Seghezzi | |
| By: | /s/ Anta Gkelou | By: | /s/ Karl Naegler | |
| Name: | Anta Gkelou | Name: | Karl Naegler | |
